Add to my selection

ESMYA (ulipristal (acétate d'))

Medicine - Posted on May 17 2019 - Updated on Jun 12 2019

Active substance (DCI)

ulipristal (acétate d')

history (5)

2/27/19

ESMYA (ulipristal (acétate d'))

Intérêt clinique insuffisant pour justifier son remboursement dans le traitement des fibromes utérins ESMYA a l’AMM pour une...

icône flèche
11/9/16

ESMYA (ulipristal), progesterone receptor modulator

No clinical benefit demonstrated in sequential treatment of moderate to severe symptoms of uterine fibroids ESMYA has Market...

CAV :
54321

icône flèche
10/5/16

ESMYA (ulipristal (acétate d'))

Maintien du remboursement dans les mêmes conditions

icône flèche
6/17/15

ESMYA (ulipristal), progesterone receptor modulator

Insufficient actual benefit in patients receiving a second 3-month course of treatment in the pre-operative treatment of mod...

CAV :
54321

icône flèche
7/18/12

ESMYA

-

CAV :
54321

icône flèche

Technical information

ATC code

G03XB02

Manufacturer

GEDEON RICHTER FRANCE

Presentation

ESMYA 5 mg, comprimé (code CIS : 60529816)
plaquette(s) de 28 comprimé(s) - Code CIP : 34009 222 578 9 1
plaquette(s) de 30 comprimé(s) - Code CIP : 34009 278 753 0 4

All our publications

Drug therapy

Female genital diseases

Operative surgical procedures

My account

You do not have a saved search

No element in selection

ESMYA (ulipristal (acétate d'))

ESMYA (ulipristal (acétate d'))

ESMYA (ulipristal), progesterone receptor modulator

ESMYA (ulipristal (acétate d'))

ESMYA (ulipristal), progesterone receptor modulator

ESMYA

Follow us :